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Risk factor Incidence of the Unlvafiata odds ratio p value 
risk factor (%) (95% CI) 
Atrial fibrilk~tion 152/8g0 (1P,~) 2.06 (1.27-3.34) <0.003 
LAP, "rh 11/535 (1%) 7.54 (2.2-25.2) <0.001 
SEC in LA 130/873 (15%) 2.94 (1.8-10.7) <0.001 
Th in ~rtic arch 20/865 (2%) 2.76 (0.98-7.7) <0.04 
SEC in aortic amh 21/869 (0%) 6.73 (2.7-16.4) <0.001 
Non ips~taral CS 91/818(11%) 2.02(1.10-,3.68) <0.01 
LAA = left atrial appendage; Th = thrombus; SEC : spontaneous echo contrast; LA = left 
atdum; Non ipsitatera! CS = Carotid stanosis (_> 60% narrowing) non ~llatera! to the el'de 
of cerebral ischemia. 
Conclusion: this preliminary analysis of the data indicated that TEE and 
CED are useful tools in identifying high risk pts for subsequent clinical events 
such as fatal or non fatal relapse of cerebral ischemia, systemic embolism or 
cardiac death within the first year after the first stroke or TIA. 
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~7~1-}  What Is the Prevalence of Hibernating Myocardium? 
Timothy F. Christian, Todd D. Miller, David O, Hodge, Raymond J. Gibbons. 
Mayo Clinic, Rochester, Minnesota 
There has been a great interest in the detection of hibernating myocardium, 
but little is known about its true prevalence in unsefected patients with care. 
nan/artery disease and abnormal vectdcular function. The purpose of this 
study was to ~certain the relevance of h~mafing myeeardium by examining 
global eft ventricular ejection fraction (LVEF) response to revascularization 
without requiring specific preoperative testing for hibemaflng myscardium 
that may cause post-test referral bias. Equitibdum redionuclide angiography 
was performed In 86 patients (76 male, 10 female) within one year prior to 
bypass surgery (46 4- 73 days) and anytime thereafter (492 :E 563 days). All 
patients had a pre*oporative r sting LVEF < 0.50. Reproducibility of ejection 
fraction by this method for an individual patient on separate acquisitions is 
4 LVEF points. A definite improvement in LVEF (post versus pre-bypass 
surgery) was defined as an increase of 8 points (950/= confidence limits) and 
a probable improvement was defined as a 4 point increase (67% confidence 
limits). Prior myocardial infarction was present in 85% of patients. There was 
no significant change in LVEF for the overall study group (0,39 4- 0.08 pre- 
versus 0.38 ± 0.10 post-bypass urgery, p = NS), although many patients 
met the above definitions for improvement: 
LVEF change < 0.04 LVEF increase > 0.04 LVEF increase > 0.08 
n (%) 58 (6"P/o) 28 (33%) 18 (21%) 
NO clinical parameters were predictive of LVEF improvement. 
Conclusion: In the absence of specific preoperative t sting that may lead 
to referral bias, the prevalence of hibamating myocardium is signiticant, 
compdsing u~: to one third of patients ent to bypass ~urgery with abnormal 
ventricular function. Noninvasive identification ofsuch patients hould remain 
a high priority. 
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~- ' )  Thallium Imaging, Oobutamine Echocardiography 
and Positron Emission Tomography for the 
Assessment of Myocardial Viability 
Hal A. Skopicki, Nell J. Weissman. Geoffrey A. Rose, Anit Mukerjee, 
Stephanie A. Coulter, Alan Fischman, Michael H. Picerd, Henry Gewirlz, 
Stephen A. Abraham, Mass General Hosp,, Boston, MA 
Thallium imaging (2°1TI), dobutamice ohocardiography (DE) and positron 
emission tomography (PET) have all been utilized to predict improved wall 
motion (IWM) after surgical revasculadzation (CABG). However, no system- 
atic comparison of all three medal(ties has been performed in the same 
patients (pts). This study tested the hypothesis that =°lTI, DE, and PET are 
equally effec:ive in predicting IWM alter CABG. Fifty-one pts with angiegraph- 
(sally proven coronary artery disease underwent ~°rTI (stress-re(nice)ion n 
= 16, rest-redistribution n = 4), DE (5--40 ug/kg/mln, modified for ItS on 
B-bidckers), and PET (NHa/FDG), Viability was assessed in a 24 segment 
model and defined as follows: 2°~TI-normalizaflon, mild-moderats fixed de= 
fects, and normal uptake, DE4WM > 1 grade, and PET-FDG/NH3 mismatch 
and mild-moderate matched defects. Twenty-seven pts underwent CABG 
and 24 were treated medically. Twenty pts (17 men, 3 women; mean age 
63 ± 12 years; mean LVEF 0.41 ± 0.17 with 10 pts _< 0.40) are presented 
herein. 
Test Sensitivity Specificity Accuracy PPV NPV 
20tTI 84.0% 52.6% 66.7% 59.7% 79.3% 
OE 66.(P/~ 77.6% 72.1% 69.0% 74.L~,~ 
PET 81.7% 76.0% 78.6% 74.1% 83.2% 
2°1TI and PET were equally and significantly more sensitive than DE 
for predicting IWM, while DE was more specific than 2°tTI (P < 0.01). A 
stepwise strategy utilizing beth 2OlTi and DE may provide viability assessment 
comparable to PET in certain pts, 
11:00 
~ ' ~  Resting Tc~ggm sestamlbi SPECT Underestimates 
Myocardial Viability in .Patients With Severe 
Ischemic Left Ventdcular Dysfunction: Comparison 
With Ammonla/FDG PET 
James A. Ardghi, Chin K. Ng, Holley Dey, Frans J. Th. Wackers, 
Robert Sourer. Yale-VAMC PET Center, West Haven, CT 
Studies investigating the utility of Tc-99m sestamibi (SM) for the detec- 
tion of viable myocerdium (VM) In patients with coronary artery disease 
(CAD) and left ventricular (LV) dysfunction have yielded conflicting results. 
In patients with severe LV dysfunction, in whom the queer(on of myocar- 
dial viability is most important, metabolic imaging with PET m~-y be needed 
for optimal detection of VM. To assess whether SM performs less favor- 
ably for VM detection in patients with severe LV dysfunction, we studied 29 
pts with chronic CAD and LV dysfunction. Pts were divided into those with 
mitd4o-moderate LV dysfunction (EF > 25%, n = 12, group 1), and severe 
LV dysfunction (EF < 25°/=, n = 17, group 2). All pts underwent quantita- 
tive SM SPECT and N-13 ammonia/FDG PET, both at rest. A total of 618 
regions were analyzed; 314 of these had abnormal resting flow by PET 
and were subs~lusn~|~ analyzed for VM and ne.~viable (NV) myocardium 
(117 and 197 regions in groups 1 and 2 respectively) using PET and SM 
SPECT: 
EF % PET Viable PET Nonviable 
SM VM SM NV SM VM SM NV 
Group I 39 ~: 8 84 (88%) 12 (1L~,=) 11 (52%) 10 (48%) 
Group 2 18 ± 5 99 (58/,) 72 (42%) I (4%) 25 (96%) 
Thus, while res~.ing SM SPECT accurately identities VM in CAD pts with 
mild-to-moderets LV dysfunction, itunderestimates the amount of VM in pts 
with CAD and severely depressed LV function. For the identification of NV 
myocardium, however, SM SPECT performs more accurately in lots with 
severely depressed LV function. 
11:15 
~ Myocardial Viability and Tcg9m-MIBI: Correlation 
With PET, Function and Histology 
Alex Maes, Wiitem Ftameng, Marcel Borgers, Paul Sergeant, Johan Nuyts, 
Guy Bormans, Frans Van de Werf. Luc Mortelmans University Hospital 
Gasthuisberg, Leuven, Belgium 
The value of Tcggm-MIBI as a viability tracer was investigated in patients 
undergoing bypass surgery (CABG). Viability was evaluated using positron 
emission tomography (PET), functional follow up after CABG and histefogic 
data, A PET Ilow (NH3) and metabolism (18FDG) study, a TCggm-MIBI rest- 
ing study and a nuclear angiography were performed 1 or 2 days before 
bypass surgery. Two preoperative transmural biopsies were taken from the 
left ventricular anterior wall. Morphometry was performed to assess the per- 
cectege fibrosis. After 3 months, a radionuclide angiography was repeated. 
30 patients were prospectively included. Statistically significant higher MIBI 
values were found in the PET mismatch group as compared to the PET 
match group (79 ± 17=/o vs 51 ± 23%, p = 0.02). A linear relationship was 
found between MIBI uptake and the amount of flbroflc tissue in the biopsy (r 
= 0.78, p < 0.0001). Significant higher MIBI values were found in the group 
with enhanced ventricular function at 3 months (78 4- 11% vs 49 4- 17=/o, 
p = 0.004). Using a cutoff point of 60% of peak for MIBI, and functional 
improvement alter surgery as gold standard for viability, a positive predic- 
tive value of 73°/= and a negative predictive value of 75% were found. It 
can be concluded that TCggm-MIBI uptake was significantly higher in PET 
mismatch areas and in regions with enhanced contractility at 3 months. A 
linear relationship was found between % fibrosis and MIBI uptake. Using a 
cutoff value of 6(P/=, positive and negative predictive values around 75% were 
found. 
